Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial

Autor: Wanner, Christoph, Cooper, Mark E., George, Jyothis T., Gollop, Nicholas D., Marx, Nikolaus, Alexander, John H., Zinman, Bernard, Perkovic, Vlado, CARMELINAinvestigators, Johansen, Odd Erik, Toto, Robert, Rosenstock, Julio, McGuire, Darren K., Kahn, Steven E., Pfarr, Egon, Schnaidt, Sven, von Eynatten, Maximilian
Jazyk: angličtina
Rok vydání: 2021
Zdroj: Clinical kidney journal 14(9), 2136-2136 (2021). doi:10.1093/ckj/sfab104
DOI: 10.18154/rwth-conv-249006
Popis: Clinical kidney journal 14(9), 2136-2136 (2021). doi:10.1093/ckj/sfab104
Published by Oxford Univ. Press, Oxford
Databáze: OpenAIRE